Document is current

Any future updates will be listed below

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study

Crossref DOI link: https://doi.org/10.1007/s00520-016-3100-y

Published Online: 2016-02-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark